Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Pharmacor Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (674)
Cancellation by sponsor (99)
Prescription medicine registration (44)
Cancellation or suspension (21)
Australian public assessment report (AusPar) (1)

Date

2026 (32)
2025 (74)
2024 (49)
2023 (53)
2022 (131)
2021 (82)
2020 (79)
2019 (56)
2018 (91)
2017 (41)
2016 (22)
2015 (13)
2014 (55)
2013 (21)
2012 (9)
2011 (7)
2010 (18)
2009 (3)
2007 (2)
1991 (1)

Search

Sponsor content

839 result(s) found, displaying 151 to 160

VARENIX varenicline (as tartrate) 0.5 mg film coated tablet bottle (395132)

17 August 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VARENIX varenicline (as tartrate) 0.5 mg film coated tablet bottle.
TOPRELOC-XL metoprolol succinate 95 mg modified release tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
TOPRELOC-XL metoprolol succinate 47.5 mg modifed release tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
TOPRELOC-XL metoprolol succinate 23.75 mg modified release tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
TOPRELOC-XL metoprolol succinate 190 mg modified release tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
PHARMACOR EZETIMIBE SIMVASTATIN 10/10 ezetimibe & simvastatin 10/10 mg tablet bottle pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
TADALACCORD tadalafil 10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
PHARMACOR EZETIMIBE SIMVASTATIN 10/40 ezetimibe & simvastatin 10/40 mg tablet bottle pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
PHARMACOR EZETIMIBE SIMVASTATIN 10/80 ezetimibe & simvastatin 10/80 mg tablet bottle pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
PHARMACOR EZETIMIBE SIMVASTATIN 10/20 ezetimibe & simvastatin 10/20 mg tablet bottle pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Pharmacor Pty Ltd

Pages

First page
Previous page
…
Page 12
Page 13
Page 14
Page 15
Current page 16
Page 17
Page 18
Page 19
Page 20
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.